BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17446330)

  • 1. Utilization and diagnostic yield of neurogenetic testing at a tertiary care facility.
    Edlefsen KL; Tait JF; Wener MH; Astion M
    Clin Chem; 2007 Jun; 53(6):1016-22. PubMed ID: 17446330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurogenetics in Argentina: diagnostic yield in a personalized research based clinic.
    Rodríguez-Quiroga SA; Cordoba M; González-Morón D; Medina N; Vega P; Dusefante CV; Arakaki T; Garretto NS; Kauffman MA
    Genet Res (Camb); 2015; 97():e10. PubMed ID: 25989649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diagnostic approach for cerebral palsy in the genomic era.
    Lee RW; Poretti A; Cohen JS; Levey E; Gwynn H; Johnston MV; Hoon AH; Fatemi A
    Neuromolecular Med; 2014 Dec; 16(4):821-44. PubMed ID: 25280894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near infrared spectroscopy with a vascular occlusion test as a biomarker in children with mitochondrial and other neuro-genetic disorders.
    Raman S; Chentouf L; DeVile C; Peters MJ; Rahman S
    PLoS One; 2018; 13(7):e0199756. PubMed ID: 29969469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.
    Garone G; Capuano A; Travaglini L; Graziola F; Stregapede F; Zanni G; Vigevano F; Bertini E; Nicita F
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA Analysis from Exome Sequencing Data Improves Diagnostic Yield in Neurological Diseases.
    Poole OV; Pizzamiglio C; Murphy D; Falabella M; Macken WL; Bugiardini E; Woodward CE; Labrum R; Efthymiou S; Salpietro V; Chelban V; Kaiyrzhanov R; Maroofian R; ; Amato AA; Gregory A; Hayflick SJ; ; Jonvik H; Wood N; Houlden H; Vandrovcova J; Hanna MG; Pittman A; Pitceathly RDS
    Ann Neurol; 2021 Jun; 89(6):1240-1247. PubMed ID: 33704825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic pathway in complex paediatric neurology: a cost analysis.
    van Nimwegen KJ; Schieving JH; Willemsen MA; Veltman JA; van der Burg S; van der Wilt GJ; Grutters JP
    Eur J Paediatr Neurol; 2015 Mar; 19(2):233-9. PubMed ID: 25604808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical approaches to neurogenetic disease.
    Lynch DR; Farmer J
    J Neuroophthalmol; 2002 Dec; 22(4):297-304. PubMed ID: 12464734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement disorders in mitochondrial diseases.
    Tranchant C; Anheim M
    Rev Neurol (Paris); 2016; 172(8-9):524-529. PubMed ID: 27476418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics: Clinical exome sequencing in neurology practice.
    Miyatake S; Matsumoto N
    Nat Rev Neurol; 2014 Dec; 10(12):676-8. PubMed ID: 25366112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of neurological and neuromuscular signs in mitochondrial diseases.
    Chaussenot A; Paquis-Flucklinger V
    Rev Neurol (Paris); 2014 May; 170(5):323-38. PubMed ID: 24792434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Disorders of the Nervous System: A Review.
    Set KK; Sen K; Huq AHM; Agarwal R
    Clin Pediatr (Phila); 2019 Apr; 58(4):381-394. PubMed ID: 30607979
    [No Abstract]   [Full Text] [Related]  

  • 13. A retrospective analysis of health care utilization for patients with mitochondrial disease in the United States: 2008-2015.
    Cohen B; Balcells C; Hotchkiss B; Aggarwal K; Karaa A
    Orphanet J Rare Dis; 2018 Nov; 13(1):210. PubMed ID: 30466460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders.
    Smith CO; Lipe HP; Bird TD
    Arch Neurol; 2004 Jun; 61(6):875-80. PubMed ID: 15210524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic challenges of mitochondrial DNA disorders.
    Wong LJ
    Mitochondrion; 2007; 7(1-2):45-52. PubMed ID: 17276740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenetic diseases: molecular diagnosis and therapeutic approaches.
    Muller U; Graeber MB
    J Mol Med (Berl); 1996 Feb; 74(2):71-84. PubMed ID: 8820402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature.
    Indelicato E; Nachbauer W; Karner E; Eigentler A; Wagner M; Unterberger I; Poewe W; Delazer M; Boesch S
    Eur J Neurol; 2019 Jan; 26(1):66-e7. PubMed ID: 30063100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder.
    Tammimies K; Marshall CR; Walker S; Kaur G; Thiruvahindrapuram B; Lionel AC; Yuen RK; Uddin M; Roberts W; Weksberg R; Woodbury-Smith M; Zwaigenbaum L; Anagnostou E; Wang Z; Wei J; Howe JL; Gazzellone MJ; Lau L; Sung WW; Whitten K; Vardy C; Crosbie V; Tsang B; D'Abate L; Tong WW; Luscombe S; Doyle T; Carter MT; Szatmari P; Stuckless S; Merico D; Stavropoulos DJ; Scherer SW; Fernandez BA
    JAMA; 2015 Sep; 314(9):895-903. PubMed ID: 26325558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias.
    Burgunder JM; Finsterer J; Szolnoki Z; Fontaine B; Baets J; Van Broeckhoven C; Di Donato S; De Jonghe P; Lynch T; Mariotti C; Schöls L; Spinazzola A; Tabrizi SJ; Tallaksen C; Zeviani M; Harbo HF; Gasser T;
    Eur J Neurol; 2010 May; 17(5):641-8. PubMed ID: 20298421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic aetiology of ophthalmological manifestations in children - a focus on mitochondrial disease-related symptoms.
    Widgren P; Hurme A; Falck A; Keski-Filppula R; Remes AM; Moilanen J; Majamaa K; Kervinen M; Uusimaa J
    Acta Ophthalmol; 2016 Feb; 94(1):83-91. PubMed ID: 26448634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.